GRP
BPMC

Global Retirement Partners’s Blueprint Medicines BPMC Stock Holding History

Global Retirement Partners’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-157
Closed -$20.1K – 3891
2025
Q2 		$20.1K Buy
+157
New +$16.3K ﹤0.01% 2290
2024
Q4 		$14K Sell
160
-15
-9% -$1.37K ﹤0.01% 2273
2024
Q3 		$16.2K Hold
175
– – ﹤0.01% 2094
2024
Q2 		$18.9K Buy
175
+16
+10% +$1.6K ﹤0.01% 2013
2024
Q1 		$15.1K Hold
159
– – ﹤0.01% 1930
2023
Q4 		$12.8K Buy
159
+11
+7% +$713 ﹤0.01% 1960
2023
Q3 		$6.84K Hold
148
– – ﹤0.01% 2093
2023
Q2 		$9.35K Hold
148
– – ﹤0.01% 1990
2023
Q1 		$7.68K Buy
+148
New +$6.67K ﹤0.01% 2015

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Global Retirement Partners's BPMC Position: Q3 2025 in Review

Global Retirement Partners sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 157 shares — an estimated $20.1K sold.

Global Retirement Partners first reported a position in BPMC in Q1 2023 and held it in 9 quarters. The position peaked at $20.1K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Global Retirement Partners reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Global Retirement Partners sold 157 Blueprint Medicines shares in Q3 2025, an estimated $20.1K.
  • Global Retirement Partners first reported a position in Blueprint Medicines in Q1 2023 and held it in 9 quarters.
  • Global Retirement Partners's Blueprint Medicines position peaked at $20.1K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Global Retirement Partners's 13F filing for Q3 2025, filed 21 Oct 2025.